Staff Scientist

• The client is seeking a temporary scientist to support the genetic characterization of cell lines expressing therapeutic proteins.

• The scientist will be primarily responsible for molecular biology activities that demonstrate genetic and epigenetic foundations of cellular phenotypes, such as ddPCR, RT-PCR, Northern blotting, Southern blotting, Next-Generation Sequencing, and molecular cloning.

• Additional responsibilities include mammalian cell culture, experimental design, data analysis, troubleshooting, participation in project teams and maintaining detailed records.

• The work is highly collaborative; requiring excellent communication skills and a desire to be part of a team.

• This temporary position is located at our Springhouse, PA facility and is expected to be needed until the end of 2016.

• Qualifications The qualified candidate will have a BA/BS/MS in biological sciences, biochemistry, chemical engineering or related scientific discipline. A minimum of 3 year of experience in a laboratory setting is required.

• Experience in mammalian cell culture, PCR, DNA/RNA isolation, and common molecular biology techniques is required.

• Familiarity with quantitative PCR and Next Generation Sequencing data analysis is preferred. 

• Excellent interpersonal, organizational, verbal and written communication skills are required.

• The incumbent candidate must be comfortable working in a matrix environment and have the ability to connect with different functional groups and people in multiple levels while embracing and driving change.

Qualifications The qualified candidate will have a BA/BS/MS in biological sciences, biochemistry, chemical engineering or related scientific discipline. A minimum of 3 year of experience in a laboratory setting is required. 

 Sneha Shrivastava

Technical Recruiter (Clinical/Scientific)

Artech Information Systems LLC

360 Mt. Kemble Avenue, Suite 2000 | Morristown, NJ 07960 

Office: 973.967.3348 | Fax: 973.998.2599

Connect with us on - LinkedIn | Facebook | Twitter